Free hemophilia a and b diagnosis Topical Map Generator
Use this free hemophilia a and b diagnosis topical map generator to plan topic clusters, pillar pages, article ideas, content briefs, AI prompts, and publishing order for SEO.
Built for SEOs, agencies, bloggers, and content teams that need a practical content plan for Google rankings, AI Overview eligibility, and LLM citation.
1. Foundations: Causes, Genetics, and Diagnosis
Covers the biological basis, inheritance, clinical presentation, and diagnostic workup for Hemophilia A and B. This group establishes the essential clinical and genetic knowledge every clinician and informed patient needs.
Hemophilia A and B: Causes, Genetics, and How They Are Diagnosed
A definitive reference on the pathophysiology and genetics of hemophilia A and B and the step-by-step diagnostic pathway. The article explains inheritance patterns, risk factors, laboratory testing (screening tests, factor assays, inhibitor testing), severity classification, and differential diagnoses, giving clinicians and families a clear diagnostic algorithm and actionable next steps.
Recognizing hemophilia symptoms by age and severity
Practical guide to the typical bleeding patterns and red flags in neonates, children, adolescents, and adults by severity (severe, moderate, mild). Includes when to seek urgent testing.
Genetic testing and counseling for hemophilia
Explains genetic testing methods, interpreting results, carrier detection, options for prenatal diagnosis, and counseling points for families considering testing.
Interpreting coagulation labs: aPTT, mixing studies and factor assays
Detailed walkthrough of common coagulation tests, how to interpret prolonged aPTT, the role of mixing studies, and stepwise use of factor assays including pitfalls and pre-analytical issues.
Carrier detection and prenatal diagnostic options
Describes carrier testing approaches, noninvasive and invasive prenatal testing options, ethical considerations, and counseling resources.
Hemophilia vs von Willebrand disease: how to distinguish them
Compares clinical features and lab patterns of hemophilia and von Willebrand disease, with a testing checklist to avoid misdiagnosis.
2. Acute Bleed Management and Emergency Care
Provides clear, actionable protocols for recognizing and managing acute bleeds, first-aid, emergency department care, and home treatment workflows to reduce morbidity and prevent disability.
Acute Bleed Management and Emergency Protocols for Hemophilia A and B
Comprehensive emergency-focused guide covering first response to bleeding, triage, factor replacement dosing in emergencies, use of desmopressin, special-case management (head injury, compartment syndrome, major trauma), and coordination with Hemophilia Treatment Centers. Includes reproducible ER checklists and sample order sets.
Home treatment: teaching patients and caregivers to infuse factor
Step-by-step how-to for training patients/caregivers on peripheral venous access, reconstitution, infusion technique, storage, and troubleshooting with safety tips.
Managing joint (hemarthrosis) bleeds: early rehab and long-term prevention
Clinical management plan for hemarthrosis including acute control, icing, immobilization, analgesia, and early physiotherapy to prevent chronic arthropathy.
Head injuries in people with hemophilia: emergency guidelines
Evidence-based protocols for evaluation, imaging thresholds, factor coverage, observation periods, and neurosurgery coordination after head trauma.
Dental procedures and bleeding management in hemophilia
Pre-procedure planning, local measures, factor cover dosages, and when to involve the HTC for extractions and invasive dental care.
Bleed emergency checklist for patients and emergency departments
Printable checklist and sample ED order set to standardize rapid, safe care during a bleeding emergency.
3. Long-term Management and Prophylaxis
Covers strategies to prevent bleeds and long-term complications: prophylaxis regimens, product selection, monitoring, adherence, and orthopedic and rehabilitation care—core content for improving lifelong outcomes.
Long-term Management and Prophylaxis Strategies for Hemophilia A and B
A comprehensive guide to preventive care including prophylaxis schedules (standard and tailored), comparing factor products (standard vs extended half-life), non-factor prophylaxis (emicizumab), monitoring strategies, adherence optimization, and integrated musculoskeletal care to preserve function and quality of life.
Prophylaxis vs on-demand treatment: evidence, benefits, and choosing a regimen
Comparative analysis of outcomes with prophylaxis versus on-demand therapy, including bleed rates, joint health, quality of life, and cost-effectiveness considerations.
Guide to factor replacement products and choosing the right one
Detailed review of product classes, pharmacokinetics, dosing implications, storage, safety (infectious risk), and practical selection guidance.
Emicizumab for hemophilia A: when to use, dosing, monitoring, and safety
Explains the mechanism of emicizumab, indications (with and without inhibitors), administration schedules, lab monitoring nuances, interactions with bypassing agents, and adverse events.
Physical therapy and orthopedic management to prevent hemophilic arthropathy
Rehabilitation protocols, exercise recommendations, indications for synovectomy or joint replacement, and long-term orthopedic follow-up strategies.
Monitoring, adherence, and telehealth tools for long-term care
Practical tools for tracking bleeds, adherence strategies, and using telemedicine and apps to improve outcomes and communication with HTCs.
4. Inhibitors and Immune Tolerance
Focused coverage of factor inhibitors—their detection, clinical impact, and advanced management including bypassing agents and immune tolerance induction—critical for any authoritative hemophilia program.
Diagnosis and Management of Inhibitors in Hemophilia A and B
Authoritative review of inhibitor immunology, risk factors, surveillance protocols, interpretation of Bethesda titers, acute management of bleeds with inhibitors, bypassing agents, and immune tolerance induction strategies with outcomes and decision algorithms.
How inhibitors are diagnosed and monitored (Bethesda assay explained)
Explains assay methodology, interpreting low- vs high-titre results, timing of testing, and laboratory pitfalls for accurate inhibitor surveillance.
Bypassing agents: rFVIIa and aPCC — indications, dosing, and safety
Clinical guide to selecting and dosing bypassing agents for acute bleeds and perioperative coverage, including thrombotic risk mitigation and monitoring.
Immune tolerance induction (ITI): protocols, outcomes, and patient selection
Detailed review of ITI approaches, success predictors, duration, adverse effects, and how to counsel families on expectations.
Managing surgery and invasive procedures in patients with inhibitors
Perioperative planning, hemostatic strategies using bypassing agents or combined approaches, and postoperative monitoring recommendations.
5. Special Populations: Pediatrics, Women, Pregnancy, and Aging
Tailors management principles to newborns, children, women/carriers, pregnant patients, and older adults—addressing unique risks, monitoring, and life-stage transitions.
Managing Hemophilia Across the Lifespan: Pediatrics, Women, Pregnancy, and Aging
Comprehensive lifecycle guidance including newborn assessment and prophylaxis initiation, school and activity advice for children, bleeding management in female carriers and pregnant persons, contraception and obstetric planning, and care priorities for aging patients with comorbidities.
Pregnancy and delivery in carriers and women with hemophilia: guidelines for obstetricians and patients
Obstetric management plan including antepartum testing, peripartum factor management, neuraxial anesthesia considerations, and postpartum hemorrhage prevention.
Hemophilia in newborns and infants: detection and early-care strategies
Immediate postnatal evaluation, safe vaccination and circumcision guidance, when to start prophylaxis, and parental education resources.
Bleeding symptoms and management in female carriers
Assessment and treatment strategies for symptomatic carriers including lab thresholds, tranexamic acid use, and collaboration with hematology.
Aging with hemophilia: managing comorbidities and joint replacement
Addresses cardiovascular risk, osteoporosis, polypharmacy, indications and perioperative strategies for orthopedic surgery in older adults with hemophilia.
6. Advanced Therapies, Clinical Trials, and Research
Explains gene therapy, novel non-factor agents, the clinical trial landscape, and evidence for new therapeutic approaches to position the site as up-to-date on cutting-edge care.
Advanced and Emerging Therapies for Hemophilia A and B: Gene Therapy, Non-Factor Agents, and Trials
In-depth review of approved and investigational advanced therapies including AAV-based gene therapy, RNAi and other non-factor approaches, long-term efficacy and safety data, patient eligibility, and practical considerations for counseling and access to trials.
Gene therapy for hemophilia A and B: mechanism, outcomes, and who is eligible
Explains AAV-based gene transfer, summary of trial outcomes and approvals, inclusion/exclusion criteria, pre-treatment counseling checklist, and real-world follow-up needs.
Non-factor therapies in development: fitusiran, concizumab, and others
Mechanisms, clinical data, dosing concepts, bleeding outcomes, and safety profiles for major non-factor agents under development or approved.
How to find, evaluate, and enroll in hemophilia clinical trials
Practical guide to trial registries, eligibility screening, informed consent, risk–benefit conversations, and working with HTCs and trial sites.
Cost, access, and insurance considerations for advanced hemophilia therapies
Analyzes pricing models, payer pathways, prior authorization, patient assistance programs, and long-term economic considerations for gene therapy and high-cost agents.
7. Practical Living, Care Coordination, and Resources
Practical, non-clinical content on living well with hemophilia—navigating HTCs, insurance, school/work accommodations, registries, and psychosocial support to improve real-world outcomes.
Living with Hemophilia: Care Coordination, Insurance, Education, and Support Resources
A pragmatic guide for patients and caregivers covering how to choose and work with a Hemophilia Treatment Center, navigate insurance and high-cost therapy authorization, school and workplace accommodations, travel and sports safety, and where to find credible support organizations and registries.
How to choose and work with a Hemophilia Treatment Center (HTC)
Explains multidisciplinary services HTCs offer, questions to ask, and how to coordinate care between local providers and the HTC.
Navigating insurance, prior authorization, and financial assistance for factor and advanced therapies
Practical steps to secure coverage, prepare documentation, appeal denials, and access manufacturer or nonprofit assistance programs.
School and workplace accommodation templates and safety plans
Downloadable templates and best-practice guidance for individualized healthcare plans, 504 plans, and workplace accommodations.
Support organizations, registries, and patient advocacy resources
Directory of leading global and national organizations, registries, helplines, and counseling resources with tips on when to contact each.
Content strategy and topical authority plan for Hemophilia A and B: Management Guide
The recommended SEO content strategy for Hemophilia A and B: Management Guide is the hub-and-spoke topical map model: one comprehensive pillar page on Hemophilia A and B: Management Guide, supported by 31 cluster articles each targeting a specific sub-topic. This gives Google the complete hub-and-spoke coverage it needs to rank your site as a topical authority on Hemophilia A and B: Management Guide.
38
Articles in plan
7
Content groups
25
High-priority articles
~6 months
Est. time to authority
Search intent coverage across Hemophilia A and B: Management Guide
This topical map covers the full intent mix needed to build authority, not just one article type.
Entities and concepts to cover in Hemophilia A and B: Management Guide
Publishing order
Start with the pillar page, then publish the 25 high-priority articles first to establish coverage around hemophilia a and b diagnosis faster.
Estimated time to authority: ~6 months